Advances in precision medicine for schizophrenia, bipolar disorder and major depressive disorder
10.3760/cma.j.cn113661-20241207-00413
- VernacularTitle:精神分裂症、双相障碍和抑郁症的精准医学进展
- Author:
Weihua YUE
1
;
Huan CHEN
1
;
Zhewei KANG
1
Author Information
1. 北京大学第六医院 北京大学精神卫生研究所 国家卫生健康委员会精神卫生学重点实验室（北京大学）国家精神心理疾病临床医学研究中心（北京大学第六医院），北京100191
- Publication Type:Journal Article
- Keywords:
Schizophrenia;
Bipolar disorder;
Depressive disorder;
Precision medicine;
Biological markers
- From:
Chinese Journal of Psychiatry
2025;58(3):177-186
- CountryChina
- Language:Chinese
-
Abstract:
The etiology of schizophrenia, bipolar disorder and major depressive disorder are complex, posing significant challenges to their diagnosis and treatment. Traditional symptom-based approaches often fall short in addressing these complexities. Precision medicine, through the integration of multi-dimensional data such as molecular genetics, peripheral biomarkers, and neuroimaging, offers promising new strategies for optimizing the diagnostic and therapeutic framework for schizophrenia, bipolar disorder and major depressive disorder. This approach allows us to achieve objective diagnosis and personalized treatment for individuals with these disorders.
